Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review)

Oncology Letters

Volumn 7, Issue 3, 2014, Pages 595-601

  Watanabe, Masami ^a,b   Nasu, Yasutomo ^a,b   Kumon, Hiromi ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cancer vaccine; Dendritic cells; Gene therapy; REIC Dkk 3

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CD14 ANTIGEN; DICKKOPF 1 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 7; STAT1 PROTEIN; STAT3 PROTEIN;

APOPTOSIS; CANCER IMMUNIZATION; DNA METHYLATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOSYLATION; HUMAN; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84892995235     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1777     Document Type: Review

References (44)

1. Schlom J: Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst 104: 599-613, 2012.
2. Drake CG: Prostate cancer as a model for tumour immunotherapy. Nat Rev Immunol 10: 580-593, 2010.
3. de Gruijl TD, van den Eertwegh AJ, Pinedo HM and Scheper RJ: Whole-cell cancer vaccination: from autologous to allogeneic tumor-and dendritic cell-based vaccines. Cancer Immunol Immunother 57: 1569-1577, 2008.
4. Yamada A, Sasada T, Noguchi M and Itoh K: Next-generation peptide vaccines for advanced cancer. Cancer Sci 104: 15-21, 2013.
5. Sugimoto M, Watanabe M, Kaku H, Li SA, Noguchi H, UekiH, Sakaguchi M, Huh NH, Nasu Y and Kumon H: Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy. Oncol Rep 28: 1645-1652, 2012.
6. Hirata T, Watanabe M, Kaku H, Kobayashi Y, Yamada H, Sakaguchi M, Takei K, Huh NH, Nasu Y and Kumon H: REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol 41: 559-564, 2012.
7. Shirakawa T: Clinical trial design for adenoviral gene therapy products. Drug News Perspect 22: 140-145, 2009.
8. Lipinski KS, Pelech S, Mountain A, Irvine AS, Kraaij R, BangmaCH, Mills KH and Todryk SM: Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity. Cancer Immunol Immunother 55: 347-354, 2006.
9. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24, 2000.
10. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M, Shimizu N and Namba M: Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 19: 117-121, 2001.
11. Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, KariyamaR, Arao Y, Miyazaki M, Tsushima T, Namba M, Kumon H and HuhNH: Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 171: 1314-1318, 2004.
12. Hsieh SY, Hsieh PS, Chiu CT and Chen WY: Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 23: 9183-9189, 2004.
13. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, EbaraS, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622, 2005.
14. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, SasakiS, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, etal: Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28: 2459-2466, 2007.
15. Yang B, Du Z, Gao YT, Lou C, Zhang SG, Bai T, Wang YJ and Song WQ: Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma. World J Gastroenterol16: 755-763, 2010.
16. Veeck J and Dahl E: Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys Acta 1825: 18-28, 2012.
17. Hayashi T, Asano H, Toyooka S, Tsukuda K, Soh J, Shien T, Taira N, Maki Y, Tanaka N, Doihara H, Nasu Y, Huh NH and MiyoshiS: DNA methylation status of REIC/Dkk-3 gene in human malignancies. J Cancer Res Clin Oncol 138: 799-809, 2012.
18. Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H and Huh NH: REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19: 363-368, 2007.
19. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, SakaguchiM, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H: Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68: 8333-8341, 2008.
20. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, OchiaiK, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, KumonH and DateH: REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72, 2009.
21. Sakaguchi M, Huh NH and Namba M: A novel tumor suppressor, REIC/Dkk-3 gene identified by our in vitro transformation model of normal human fibroblasts works as a potent therapeutic anti-tumor agent. Adv Exp Med Biol 720: 209-215, 2011.
22. Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M, Ochiai K, etal: Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol 37: 1495-1501, 2010.
23. Kobayashi K, Ouchida M, Tsuji T, Hanafusa H, Miyazaki M, Namba M, Shimizu N and Shimizu K: Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 282: 151-158, 2002.
24. Pinho S and Niehrs C: Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction. Differentiation 75: 957-967, 2007.
25. Onai T, Takai A, Setiamarga DH and Holland LZ: Essential role of Dkk3 for head formation by inhibiting Wnt/β-catenin and Nodal/Vg1 signaling pathways in the basal chordate amphioxus. Evol Dev 14: 338-350, 2012.
26. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J and Kypta RM: Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25: 6528-6537, 2006.
27. Romero D, Kawano Y, Bengoa N, Walker MM, Maltry N, NiehrsC, Waxman J and Kypta R: Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-β/Smad signaling. J Cell Sci 126: 1858-1867, 2013.
28. Karamariti E, Margariti A, Winker B, Wang X, Hong X, BabanD, Ragoussis J, Huang Y, Han JD, Wong MM, Sag CM, etal: Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signalling are potent for tissue engineering of vascular grafts. Circ Res 112: 1433-1443, 2013.
29. Nakamura RE and Hackam AS: Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 28: 232-242, 2010.
30. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 124: 287-297, 2009.
31. Ochiai K, Watanabe M, Ueki H, Huang P, Fujii Y, Nasu Y, NoguchiH, Hirata T, Sakaguchi M, Huh NH, KashiwakuraY, etal: Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem Biophys Res Commun 412: 391-395, 2011.
32. Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH and Wang FS: Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction. J Am Soc Nephrol 21: 124-135, 2010.
33. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, FutamiJ, LiSA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and KumonH: Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 34: 657-663, 2009.
34. Cunningham NS, Paralkar V and Reddi AH: Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta1 mRNA expression. Proc Natl Acad Sci USA 89: 11740-11744, 1992.
35. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC and Pulendran B: Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329: 849-853, 2010.
36. Valencia J, Hernández-López C, Martínez VG, Hidalgo L, Zapata AG, Vicente Á, Varas A and Sacedón R: Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features. J Immunol 187: 4129-4139, 2011.
37. Van den Bossche J, Malissen B, Mantovani A, De Baetselier P and Van Ginderachter JA: Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. Blood 119: 1623-1633, 2012.
38. Niwa H, Yamamura K and Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991.
39. Araki K, Araki M, Miyazaki J and Vassalli P: Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92: 160-164, 1995.
40. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, WatanabeM, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, NasuY, etal: Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. JBiol Chem 284: 14236-14244, 2009.
41. Mizobuchi Y, Matsuzaki K, Kuwayama K, Kitazato K, MureH, Kageji T and Nagahiro S: REIC/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol 10: 244-253, 2008.
42. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T, Watanabe M, Huh NH and Kumon H: Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 14: 765-772, 2007.
43. Than SS, Kataoka K, Sakaguchi M, Murata H, Abarzua F, TaketaC, Du G, Yashiro M, Yanagihara K, Nasu Y, Kumon H and HuhNH: Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma. Oncol Rep 25: 989-995, 2011.
44. + natural killer cells. A comparative study. JImmunol 147: 2208-2214, 1991.